Houghton A - Search Results

1

HDM2 protein overexpression and prognosis in primary malignant melanoma.

Polsky D, Melzer K, Hazan C, Panageas KS, Busam K, Drobnjak M, Kamino H, Spira JG, Kopf AW, Houghton A, Cordon-Cardo C, Osman I. Polsky D, et al. Among authors: houghton a. J Natl Cancer Inst. 2002 Dec 4;94(23):1803-6. doi: 10.1093/jnci/94.23.1803. J Natl Cancer Inst. 2002. PMID: 12464652

2

Frequent p16-independent inactivation of p14ARF in human melanoma.

Freedberg DE, Rigas SH, Russak J, Gai W, Kaplow M, Osman I, Turner F, Randerson-Moor JA, Houghton A, Busam K, Timothy Bishop D, Bastian BC, Newton-Bishop JA, Polsky D. Freedberg DE, et al. Among authors: houghton a. J Natl Cancer Inst. 2008 Jun 4;100(11):784-95. doi: 10.1093/jnci/djn157. Epub 2008 May 27. J Natl Cancer Inst. 2008. PMID: 18505964 Free PMC article.

3

HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma.

Polsky D, Bastian BC, Hazan C, Melzer K, Pack J, Houghton A, Busam K, Cordon-Cardo C, Osman I. Polsky D, et al. Among authors: houghton a. Cancer Res. 2001 Oct 15;61(20):7642-6. Cancer Res. 2001. PMID: 11606406

4

Focus on melanoma.

Houghton AN, Polsky D. Houghton AN, et al. Cancer Cell. 2002 Oct;2(4):275-8. doi: 10.1016/s1535-6108(02)00161-7. Cancer Cell. 2002. PMID: 12398891 Free article. Review. No abstract available.

5

Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.

Gorden A, Osman I, Gai W, He D, Huang W, Davidson A, Houghton AN, Busam K, Polsky D. Gorden A, et al. Among authors: houghton an. Cancer Res. 2003 Jul 15;63(14):3955-7. Cancer Res. 2003. PMID: 12873990

6

Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D. Ben-Porat L, et al. Among authors: houghton an. Cancer. 2006 Jan 1;106(1):163-71. doi: 10.1002/cncr.21594. Cancer. 2006. PMID: 16331596 Free article.

7

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: houghton an. J Clin Oncol. 2003 May 1;21(9):1775-81. doi: 10.1200/JCO.2003.10.108. J Clin Oncol. 2003. PMID: 12721254

8

Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.

Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: houghton an. Cancer. 2005 Jun 15;103(12):2590-7. doi: 10.1002/cncr.21081. Cancer. 2005. PMID: 15861414 Free article. Clinical Trial.

9

Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.

Hwu WJ, Panageas KS, Menell JH, Lamb LA, Aird S, Krown SE, Williams LJ, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: houghton an. Cancer. 2006 Jun 1;106(11):2445-51. doi: 10.1002/cncr.21909. Cancer. 2006. PMID: 16639739 Free article. Clinical Trial.

10

Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells.

Nasi ML, Lieberman P, Busam KJ, Prieto V, Panageas KS, Lewis JJ, Houghton AN, Chapman PB. Nasi ML, et al. Among authors: houghton an. Cytokines Cell Mol Ther. 1999 Sep;5(3):139-44. Cytokines Cell Mol Ther. 1999. PMID: 10641571 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

556 results

Search Page

Filters